This study demonstrated that SYT13 was preferentially expressed in hormone receptor-positive BC cell lines and clinical samples based on biochemical analyses and the TCGA database analyses, but there was no significant relationship between its expression and tumor-nodes-metastasis (TNM) staging or prognosis. This evidence concerns the gene NR4A1 and breast cancer.